Genomic subpopulations and health systems responses
Event: WorkshopStart date: 22 Apr 2010 09:30
End date: 22 Apr 2010 17:00
Organised by: Dr Susan Kelly, Egenis
Venue: Exeter University
This workshop is part of the ESRC Genomics Network's 'Health Technologies and Health Systems' Workstream.
The first workshop of this workstream examined the impacts of genomics on disease classification; examining reclassification of cancers and psychiatric disorders and how these may impact treatment approaches. It concluded with a look at health economics and how genomics might feed into health system decision making regarding diagnostic and treatment options.
The second workshop continues some of these themes with a more direct emphasis on health system. We will look at specific instances of health system response to genetic heterogeneity of disease within the populations they serve. The intent of this workshop is to look at genetic heterogeneity of diseases with impacts on health systems, and what measures in terms education, infrastructure, investment in research and/or technology, and policy, health system might engage to improve disease management. What implications for health systems follow, for example, from the genomics of common complex diseases? Are medical advances stemming from genomics increasing disparities in health systems between wealthy and poor countries? What models are emerging for addressing this gap, and how successful are they likely to be? What are the implications of population genetic heterogeneity with regard to susceptibility to disease or treatment response, particularly for the health systems of developing countries? What might ‘personalised medicine’ look like in the context of diverse health systems, and with what implications for the division of labour among health professionals and overall structure of care?
Potential topics for workshop presentations include:
- Rare population variants with significant individual treatment implications and health system responses; e.g., the case of MODY diabetes
- Genetic heterogeneity of high impact disease within a population and health system responses, e.g., thalassaemia or blood group typing across and within national boundaries and populations
- How genetic heterogeneity of common complex disease such as diabetes, or conditions such as obesity, is being understood and how this knowledge might move into health systems.
- Pharmacogenetics in the context of developing countries.
- Genetic heterogeneity in immunity to infectious diseases or parasites, and health system responses.
Further details: Dr Susan Kelly, Egenis - s.e.kelly@exeter.ac.uk
back
